1. The Future of the Quinolones

   • Vincent T. Andriole

   Oral Presentations 01 December 2012 Pages: 1 - 5

2. Mode of Action of Fluoroquinolones

   • David C. Hooper

   Oral Presentations 01 December 2012 Pages: 6 - 10

3. Mechanisms of Fluoroquinolone Resistance: An Update 1994–1998

   • Laura J. V. Piddock

   Oral Presentations 01 December 2012 Pages: 11 - 18

4. Activity of Quinolones Against Mycobacteria

   • Michael R. Jacobs

   Oral Presentations 01 December 2012 Pages: 19 - 22

5. Activity of Newer Fluoroquinolones In Vitro Against Gram-Positive Bacteria

   • George M. Eliopoulos

   Oral Presentations 01 December 2012 Pages: 23 - 28

6. Pharmacokinetics and Pharmacodynamics of Fluoroquinolones

   • John Turnidge

   Oral Presentations 01 December 2012 Pages: 29 - 36

7. Toxicity of Quinolones

   • Ralf Stahlmann
   • Hartmut Lode

   Oral Presentations 01 December 2012 Pages: 37 - 42

8. Fluoroquinolones in Paediatrics

   • Hasan S. Jafri
   • George H. McCracken Jr

   Oral Presentations 01 December 2012 Pages: 43 - 48

9. Quinolones in the Aged

   • Lindsay E. Nicolle

   Oral Presentations 01 December 2012 Pages: 49 - 51

10. Quinolones in the Treatment of Typhoid Fever

    • H. Erdal Akalin

    Oral Presentations 01 December 2012 Pages: 52 - 54

11. Quinolone Use in the Developing World

    • Thelma E. Tupasi

    Oral Presentations 01 December 2012 Pages: 55 - 59

12. Quinolone Activity Against Anaerobes

    • Peter C. Appelbaum

    Oral Presentations 01 December 2012 Pages: 60 - 64

13. Effect of Quinolones on Intestinal Ecology

    • Charlotta Edlund
    • Carl Erik Nord

    Oral Presentations 01 December 2012 Pages: 65 - 70

14. Cost Effectiveness of Quinolones in Hospitals and the Community

    • Peter Davey

    Oral Presentations 01 December 2012 Pages: 71 - 77

15. Activity of Quinolones Against Chlamydia pneumoniae

    • Margaret R. Hammerschlag

    Oral Presentations 01 December 2012 Pages: 78 - 81

16. Fluoroquinolone Treatment of Skin and Skin Structure Infections

    • Adolf W. Karchmer

    Oral Presentations 01 December 2012 Pages: 82 - 84

17. Use of Quinolones in Osteomyelitis and Infected Orthopaedic Prosthesis

    • Daniel P. Lew
    • Francis A. Waldvogel

    Oral Presentations 01 December 2012 Pages: 85 - 91

18. Quinolones in Sexually Transmitted Diseases

    • Geoffrey L. Ridgway

    Oral Presentations 01 December 2012 Pages: 92 - 95

19. The Quinolones and Renal Infection

    • Allan Ronald

    Oral Presentations 01 December 2012 Pages: 96 - 98

20. Newer Quinolones in the Long Term Prophylaxis of Recurrent Urinary Tract Infections (UTI)

    • Silvester Krcméry
    • Juraj Hromec
    • Dusan Gulla

    Oral Presentations 01 December 2012 Pages: 99 - 102

21. Outcome of Antibiotic Therapy with Ciprofloxacin in Chronic Bacterial Prostatitis

    • Wolfgang Weidner
    • Martin Ludwig
    • Hans Gerd Schiefer

    Oral Presentations 01 December 2012 Pages: 103 - 106

22. Antimicrobial Activity of Gatifloxacin Against Campylobacter jejuni and Anaerobic Bacteria

    • M. E. Erwin
    • R. N. Jones
    • G. V. Doern

    Poster Presentations 01 December 2012 Pages: 107 - 109

23. Antianaerobic Activity of Grepafloxacin Compared with Ofloxacin, Ciprofloxacin, Clindamycin, Metronidazole and 5 β-Lactams

    • Luc Dubreuil
    • E. Singer
    • F. Leblanc

    Poster Presentations 01 December 2012 Pages: 110 - 112

24. Antianaerobic Activity of Gatifloxacin

    • Lois M. Ednie
    • Michael R. Jacobs
    • Peter C. Appelbaum

    Poster Presentations 01 December 2012 Pages: 113 - 110

25. Grepafloxacin vs Pneumococci Resistant to Fluoroquinolones by a Putative Efflux Mechanism

    • Nigel P. Brenwald
    • Martin J. Gill
    • Richard Wise

    Poster Presentations 01 December 2012 Pages: 117 - 118

26. Mutations to Quinolone Resistance in Pseudomonas aeruginosa and Enterococcus faecium

    • Shah Jalal
    • Nagwa El Amin
    • Bengt Wretlind

    Poster Presentations 01 December 2012 Pages: 119 - 120

27. Activity of Trovafloxacin Against Topoisomerases and GyrA/Gr1A Mutants of Staphylococcus aureus

    • Thomas D. Gootz
    • Richard P. Zaniewski
    • Alison E. Maurice

    Poster Presentations 01 December 2012 Pages: 121 - 122

28. Ofloxacin Selects First-Step ParC Mutations in Mycoplasma hominis Whereas Sparfloxacin Selects for First-Step GyrA Mutations

    • G. E. Kenny
    • P. A. Young
    • W. M. Huang

    Poster Presentations 01 December 2012 Pages: 123 - 124

29. Fluoroquinolone Resistance Mutations in the DNA Topoisomerase II Genes of Viridans Group Streptococci Clinical Isolates

    • Delia Balas
    • Irene González
    • Adela G. De La Campa

    Poster Presentations 01 December 2012 Pages: 125 - 127

30. Nosocomial Superinfections with Gram-Negative Pathogens and Quinolone Resistance after Treatment with Ciprofloxacin vs Ofloxacin

    • Yehuda Carmeli
    • Matthew H. Samore

    Poster Presentations 01 December 2012 Pages: 128 - 129

31. Resistant Mutants of Staphylococcus aureus with Ofloxacin in Comparison with Ciprofloxacin

    • Y. Rio
    • F. Jurin
    • J. Didion

    Poster Presentations 01 December 2012 Pages: 130 - 131

32. Mechanisms and Frequency of Resistance to Moxifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus

    • Dilek Ince
    • Rahul Aras
    • David C. Hooper

    Poster Presentations 01 December 2012 Pages: 132 - 133

33. Mechanisms and Frequency of Resistance to Gatifloxacin in Comparison with Ciprofloxacin in Staphylococcus aureus

    • Dilek Ince
    • Rahul Aras
    • David C. Hooper

    Poster Presentations 01 December 2012 Pages: 134 - 135

34. Mutational Resistance to Quinolones in Staphylococci

    • Kenneth S. Thomson
    • Ellen S. Moland
    • Christine C. Sanders

    Poster Presentations 01 December 2012 Pages: 136 - 137

35. Comparative In Vitro Activity of Grepafloxacin Against Selected Mutants and Clinical Isolates

    • C. J. Soussy
    • F. Leblanc

    Poster Presentations 01 December 2012 Pages: 138 - 140

36. Synergistic Activity of Trovafloxacin with Other Agents

    • Melissa A. Visalli
    • Saralee Bajaksouzian
    • Peter C. Appelbaum

    Poster Presentations 01 December 2012 Pages: 141 - 143

37. Antimicrobial Activity of Moxifloxacin and Levofloxacin Photodegradation Products

    • C. M. Tobin
    • J. Sunderland
    • L. O. White

    Poster Presentations 01 December 2012 Pages: 144 - 145

38. Comparative Postantibiotic Effect of Sitafloxacin and Trovafloxacin on Methicillin-Resistant Staphylococcus aureus

    • E. J. Giamarellos-Bourboulis
    • P. Grecka
    • H. Giamarellou

    Poster Presentations 01 December 2012 Pages: 146 - 148

39. Synergistic In Vitro Activity of Clinafloxacin

    • M. B. Perri
    • M. J. Zervos

    Poster Presentations 01 December 2012 Pages: 149 - 150

40. Comparative Antibiotic Activity Versus Vancomycin Intermediate-Susceptible Staphylococcus aureus

    • M. D. Huband
    • M. A. Cohen
    • S. R. VanderRoest

    Poster Presentations 01 December 2012 Pages: 151 - 153

41. Activity of Trovafloxacin Against Micro-Organisms Isolated from Diabetic Patients with Lower Extremity Infections

    • K. Weiss
    • M. Laverdière
    • L. Poirier

    Poster Presentations 01 December 2012 Pages: 154 - 155

42. Moxifloxacin

    • A. Speciale
    • G. Aleo
    • G. Nicoletti

    Poster Presentations 01 December 2012 Pages: 156 - 159

43. Antistaphylococcal Activity of Moxifloxacin

    • A. Dalhoff

    Poster Presentations 01 December 2012 Pages: 160 - 161

44. Antimicrobial Activity of Gatifloxacin Tested Against 1676 Gram-Positive Cocci Resistant to Ciprofloxacin

    • R. N. Jones
    • M. A. Pfaller
    • The SENTRY Participants Group

    Poster Presentations 01 December 2012 Pages: 162 - 163

45. Antistreptococcal Activity of Gatifloxacin

    • Ronald N. Jones
    • David M. Johnson
    • Douglas J. Biedenbach

    Poster Presentations 01 December 2012 Pages: 164 - 166

46. Antibacterial Activity of Gatifloxacin in Obstetrics and Gynaecology

    • Koji Izumi
    • Hiroshige Mikamo
    • Teruhiko Tamaya

    Poster Presentations 01 December 2012 Pages: 166 - 168

47. In Vitro Antibacterial Activities of Gatifloxacin (AM-1155) Against Clinical Pathogens Recently Isolated from Various Infections

    • Youko Tsurumaki
    • Hinako Manda
    • Yasuo Oomori

    Poster Presentations 01 December 2012 Pages: 169 - 170

48. Ofloxacin Photodegradation Products Possess Antimicrobial Activity

    • J. Sunderland
    • C. M. Tobin
    • A. J. Hedges

    Poster Presentations 01 December 2012 Pages: 171 - 172

49. Antimicrobial Spectrum of Gatifloxacin in the SENTRY Program

    • R. N. Jones
    • M. A. Pfaller
    • the SENTRY Participant Group

    Poster Presentations 01 December 2012 Pages: 173 - 175

50. Gatifloxacin Susceptibility Testing Interpretive Criteria and Quality Control Guidelines for Dilution and Disk Diffusion Methods

    • K. C. Kugler
    • R. N. Jones
    • the Quality Control Study Group

    Poster Presentations 01 December 2012 Pages: 176 - 177